← United States · Coverage record
US · SEC FORM 4
BIODESIX INC
BDSX · Nasdaq · CIK 0001439725 · Healthcare · Diagnostics & Research
INSIDER SIGNAL
1 buyers · 3 purchase transaction lines · $1.0M gross purchase
WHY THIS SIGNAL?
Score anatomy
Each bar shows the contribution to the current score; the weights and formula stay unchanged.
What is holding the score back?
- ⚠ Cluster breadth is moderate · 1 insider(s), not 4+
- ⚠ Role scores low · most senior buyer: TenPercentOwner,Other (CEO, chair and 10% owners score lowest)
- ⚠ Purchase activity is becoming less recent
Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.
US-v1.2 ranks qualifying equity purchases under the current 180-day rules. The score is a research priority, not a return forecast or probability. Backtests have not shown that a higher US score is followed by better returns.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
—
Purchase breadth & concentration
Roles in the peak window: TenPercentOwner,Other. Concentration uses priced qualifying P lines only and does not change the saved score.
SIGNAL HISTORY
Latest recorded score
- 52.3
- 52.2
- 52.2
- 52.0
- 51.9
Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.
Price performance
- 1M
- -0.1%
- 3M
- +21.5%
- 6M
- +98.2%
- 12M
- +235.7%
Volatility & liquidity
- Volatility
- 112.9%
- Beta
- —
- Avg daily value
- USD 2.6M
Valuation
- Market cap
- USD 274.5M
- P/E
- —
Fundamentals
- Profit margin
- -39.9%
- ROE
- —
- Industry
- Diagnostics & Research
Market data
Price data up to: 2026-10-11 · Price source: OpenBB/yfinance; volume from price cache (yfinance) · From SEC filings: Market cap, Profit margin · Fiscal year ended: 2025-12-31 · Market cap is the shares outstanding stated on the filing cover multiplied by the latest close. Share count date: 2026-07-30 · Status: PASS
Short interest
Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.
- Shares short
- 201,849
- Previous report
- 214,006
- Avg daily volume
- 109,841
- Days to cover
- 1.8
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-08-12 | SCHULER JACK W | Purchase (P) | Common Stock | 15,000 | USD 24.47 | USD 367,050 | SEC filing ↗ |
| 2026-08-11 | SCHULER JACK W | Purchase (P) | Common Stock | 13,700 | USD 24.01 | USD 328,937 | SEC filing ↗ |
| 2026-08-10 | SCHULER JACK W | Purchase (P) | Common Stock | 13,900 | USD 24.25 | USD 337,075 | SEC filing ↗ |
| 2026-01-26 | SCHULER JACK W | Purchase (P) | Common Stock | 20,000 | USD 11.80 | USD 236,000 | SEC filing ↗ |
| 2026-01-23 | SCHULER JACK W | Purchase (P) | Common Stock | 80,000 | USD 11.81 | USD 944,800 | SEC filing ↗ |
| 2026-01-22 | SCHULER JACK W | Purchase (P) | Common Stock | 82,465 | USD 10.96 | USD 903,816 | SEC filing ↗ |
| 2025-09-19 | SCHULER JACK W | Purchase (P) | Common Stock | 142,045 | USD 7.04 | USD 999,997 | SEC filing ↗ |
| 2025-09-18 | SCHULER JACK W | Purchase (P) | Common Stock | 3,056 | USD 6.17 | USD 18,856 | SEC filing ↗ |
| 2025-09-17 | SCHULER JACK W | Purchase (P) | Common Stock | 15,317 | USD 6.04 | USD 92,515 | SEC filing ↗ |
| 2025-08-29 | SCHULER JACK W | Purchase (P) | Common Stock | 3,488,372 | USD 0.43 | USD 1,500,000 | SEC filing ↗ |
| 2025-05-19 | SCHULER JACK W | Purchase (P) | Common Stock | 723,239 | USD 0.34 | USD 245,901 | SEC filing ↗ |
| 2025-05-16 | SCHULER JACK W | Purchase (P) | Common Stock | 4,000,000 | USD 0.27 | USD 1,080,000 | SEC filing ↗ |
| 2024-11-21 | SCHULER JACK W | Purchase (P) | Common Stock | 100,000 | USD 1.23 | USD 123,000 | SEC filing ↗ |
| 2024-11-21 | Kennedy Lawrence T. Jr | Purchase (P) | Common Stock | 35,000 | USD 1.16 | USD 40,600 | SEC filing ↗ |
| 2024-11-20 | SCHULER JACK W | Purchase (P) | Common Stock | 200,000 | USD 1.17 | USD 234,000 | SEC filing ↗ |
Form 4 evidence
49 transaction lines in the latest 365-day window; 393 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-09-30 | PATIENCE JOHN | Option exercise / conversion (M) | Common Stock | 1,360 | USD — | USD — | SEC filing ↗ |
| 2026-08-12 | SCHULER JACK W | Purchase (P) | Common Stock | 15,000 | USD 24.47 | USD 367,050 | SEC filing ↗ |
| 2026-08-11 | SCHULER JACK W | Purchase (P) | Common Stock | 13,700 | USD 24.01 | USD 328,937 | SEC filing ↗ |
Show recent Form 4 evidence (30 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-09-30 | PATIENCE JOHN | Option exercise / conversion (M) | Common Stock | 1,360 | USD — | USD — | SEC filing ↗ |
| 2026-08-12 | SCHULER JACK W | Purchase (P) | Common Stock | 15,000 | USD 24.47 | USD 367,050 | SEC filing ↗ |
| 2026-08-11 | SCHULER JACK W | Purchase (P) | Common Stock | 13,700 | USD 24.01 | USD 328,937 | SEC filing ↗ |
| 2026-08-10 | SCHULER JACK W | Purchase (P) | Common Stock | 13,900 | USD 24.25 | USD 337,075 | SEC filing ↗ |
| 2026-06-30 | PATIENCE JOHN | Option exercise / conversion (M) | Common Stock | 1,361 | USD — | USD — | SEC filing ↗ |
| 2026-02-23 | Vazquez Chris | Sale (S) | Common Stock | 211 | USD 12.78 | USD 2,697 | SEC filing ↗ |
| 2026-02-23 | Pestano Gary Anthony | Sale (S) | Common Stock | 556 | USD 12.78 | USD 7,106 | SEC filing ↗ |
| 2026-02-23 | O'Kane Kieran | Sale (S) | Common Stock | 535 | USD 12.78 | USD 6,837 | SEC filing ↗ |
| 2026-02-23 | Hutton Scott | Sale (S) | Common Stock | 1,490 | USD 12.78 | USD 19,042 | SEC filing ↗ |
| 2026-02-23 | Cowie Robin Harper | Sale (S) | Common Stock | 535 | USD 12.78 | USD 6,837 | SEC filing ↗ |
| 2026-02-20 | Vazquez Chris | Option exercise / conversion (M) | Common Stock | 563 | USD — | USD — | SEC filing ↗ |
| 2026-02-20 | Pestano Gary Anthony | Option exercise / conversion (M) | Common Stock | 1,528 | USD — | USD — | SEC filing ↗ |
| 2026-02-20 | O'Kane Kieran | Option exercise / conversion (M) | Common Stock | 1,469 | USD — | USD — | SEC filing ↗ |
| 2026-02-20 | Hutton Scott | Option exercise / conversion (M) | Common Stock | 4,844 | USD — | USD — | SEC filing ↗ |
| 2026-02-20 | Cowie Robin Harper | Option exercise / conversion (M) | Common Stock | 1,469 | USD — | USD — | SEC filing ↗ |
| 2026-02-10 | Vazquez Chris | Sale (S) | Common Stock | 101 | USD 10.08 | USD 1,018 | SEC filing ↗ |
| 2026-02-10 | Pestano Gary Anthony | Sale (S) | Common Stock | 540 | USD 10.08 | USD 5,443 | SEC filing ↗ |
| 2026-02-10 | O'Kane Kieran | Sale (S) | Common Stock | 584 | USD 10.08 | USD 5,887 | SEC filing ↗ |
| 2026-02-10 | Hutton Scott | Sale (S) | Common Stock | 3,559 | USD 10.08 | USD 35,875 | SEC filing ↗ |
| 2026-02-10 | Cowie Robin Harper | Sale (S) | Common Stock | 941 | USD 10.08 | USD 9,485 | SEC filing ↗ |
| 2026-02-09 | Vazquez Chris | Option exercise / conversion (M) | Common Stock | 263 | USD — | USD — | SEC filing ↗ |
| 2026-02-09 | Pestano Gary Anthony | Option exercise / conversion (M) | Common Stock | 1,481 | USD — | USD — | SEC filing ↗ |
| 2026-02-09 | O'Kane Kieran | Option exercise / conversion (M) | Common Stock | 1,600 | USD — | USD — | SEC filing ↗ |
| 2026-02-09 | Hutton Scott | Option exercise / conversion (M) | Common Stock | 9,998 | USD — | USD — | SEC filing ↗ |
| 2026-02-09 | Cowie Robin Harper | Option exercise / conversion (M) | Common Stock | 2,584 | USD — | USD — | SEC filing ↗ |
| 2026-01-26 | SCHULER JACK W | Purchase (P) | Common Stock | 20,000 | USD 11.80 | USD 236,000 | SEC filing ↗ |
| 2026-01-23 | SCHULER JACK W | Purchase (P) | Common Stock | 80,000 | USD 11.81 | USD 944,800 | SEC filing ↗ |
| 2026-01-22 | SCHULER JACK W | Purchase (P) | Common Stock | 82,465 | USD 10.96 | USD 903,816 | SEC filing ↗ |
| 2026-01-16 | Vazquez Chris | Sale (S) | Common Stock | 83 | USD 8.15 | USD 676 | SEC filing ↗ |
| 2026-01-16 | Pestano Gary Anthony | Sale (S) | Common Stock | 298 | USD 8.15 | USD 2,429 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | BDSX |
| CIK | 0001439725 |
| Sector | Healthcare |
| Industry | Diagnostics & Research Yahoo Finance |
| SEC SIC | 8071 Services-Medical Laboratories |
| Exchange | Nasdaq |
Data coverage
| Local Form 4 history | 393 transaction lines from 2020-10-30 to 2026-09-30 81 P purchase lines · 134 S sale lines · 178 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.